Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade

1 The present invention provides compounds of Formula (I): wherein A, B, C, G, and Whave any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.